Dai ichi Life Insurance Company Ltd lowered its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 12.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 51,243 shares of the financial services provider’s stock after selling 7,527 shares during the period. Dai ichi Life Insurance Company Ltd’s holdings in CME Group were worth $11,307,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of CME. Waverly Advisors LLC acquired a new stake in CME Group during the 1st quarter worth approximately $1,769,000. California State Teachers Retirement System increased its position in shares of CME Group by 0.6% in the first quarter. California State Teachers Retirement System now owns 580,622 shares of the financial services provider’s stock worth $125,002,000 after acquiring an additional 3,476 shares in the last quarter. Brown Shipley& Co Ltd raised its stake in shares of CME Group by 1.0% in the 1st quarter. Brown Shipley& Co Ltd now owns 7,376 shares of the financial services provider’s stock valued at $1,564,000 after acquiring an additional 74 shares during the period. Garner Asset Management Corp lifted its holdings in shares of CME Group by 1.3% during the 1st quarter. Garner Asset Management Corp now owns 11,885 shares of the financial services provider’s stock valued at $2,559,000 after acquiring an additional 156 shares in the last quarter. Finally, Plato Investment Management Ltd boosted its position in CME Group by 617.3% during the 1st quarter. Plato Investment Management Ltd now owns 14,589 shares of the financial services provider’s stock worth $3,141,000 after purchasing an additional 12,555 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Price Performance
CME opened at $229.37 on Tuesday. The company has a market capitalization of $82.66 billion, a P/E ratio of 24.12, a PEG ratio of 5.28 and a beta of 0.55. The company has a 50-day moving average of $223.86 and a 200-day moving average of $211.19. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.74.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.
Analysts Set New Price Targets
Several research analysts have commented on the company. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. Citigroup raised their target price on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. TD Cowen began coverage on CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Piper Sandler lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average target price of $224.47.
View Our Latest Research Report on CME
Insiders Place Their Bets
In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at approximately $2,403,279.44. This trade represents a 8.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 over the last 90 days. 0.30% of the stock is owned by company insiders.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- What is the Dogs of the Dow Strategy? Overview and Examples
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
- Ride Out The Recession With These Dividend Kings
- Gold’s Post-Election Moves: Key Investment Opportunities
- What is the Dow Jones Industrial Average (DJIA)?
- Bath & Body Works Stock Jumps 17%: Is More Growth Ahead?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.